PFIZERNSEPfizer Limited· PharmaceuticalsMediumNeutral
Announced Tue, 1 Apr · 19:12 IST

Intimation regarding change in Senior Management Personnel of the Company.

Management Changes View source PDF

PFIZER · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Pfizer Limited has informed the stock exchanges about a change in its Senior Management Personnel. Senior Management Personnel typically include key roles such as the CEO, CFO, and other senior executives who carry significant decision-making responsibility. The specific nature of the change (resignation, appointment, or internal movement), the name of the person involved, and the effective date are not stated in the headline. This is a routine corporate disclosure required under SEBI listing regulations whenever there is a change in key managerial personnel. Investors should look for the detailed filing or follow-up announcement from the company to understand whether this is an exit or a new hire, and which role is affected.

Likely market impact

Without details on who is leaving or joining and in what capacity, the immediate impact on shareholders or stock price is unclear. If it turns out to be a CEO or CFO-level exit, it could affect investor sentiment; if it is a planned succession or routine transition, the impact may be minimal.